Table 2 Innovative and biosimilar drugs used to treat rheumatoid arthritis (RA), approved from 1998 to 2019, in the countries analyzed
From: Drug prices in Latin American countries: the case of rheumatoid arthritis Biosimilars
Drugs | Registration year | Country |
|---|---|---|
Abatacept | 2005 | US |
2007 | Brazil | |
2012 | Spain | |
2016 | Mexico | |
2018 | Colombia | |
Adalimumab | 2002 | US |
2003 | Brazil/Colombia | |
2010 | Mexico | |
2018 | Spain | |
Adalimumab | 2018 | Spain |
Biosimilar | 2019 | Brazil/Colombia |
2015 | US | |
Baricitinib | 2017 | Spain/Mexico |
2018 | US/Brazil | |
2019 | Colombia | |
Certolizumabe pegol | 2009 | US |
2011 | Brazil | |
2016 | Colombia | |
2017 | Spain/Mexico | |
Etanercept | 1999 | Mexico |
2002 | US | |
2003 | Brazil | |
2006 | Spain | |
2007 | Colombia | |
Etanercept biosimilar | 2006 | Colombia |
2013 | Brazil/Mexico | |
2016 | US | |
2017 | Spain | |
Golimumab | 2009 | US |
2011 | Brazil/Colombia | |
2013 | Spain | |
2014 | Mexico | |
Infliximab | 1999 | Spain |
2000 | Colombia | |
2001 | US | |
2007 | Brazil | |
2016 | Mexico | |
Infliximab | 2014 | Spain/Mexico |
Biosimilar | 2013 | US |
2015 | Brazil | |
2017 | Colombia | |
Rituximab | 1998 | Brazil/Spain |
1999 | Colombia | |
2006 | US | |
2017 | Mexico | |
Rituximab | 2017 | Spain/Mexico |
Biosimilar | 2019 | Brazil |
Tocilizumab | 2009 | Brazil/Mexico |
2010 | US | |
2014 | Spain | |
2015 | Colombia | |
Tofacitinib | 2012 | US |
2013 | Mexico | |
2014 | Brazil | |
2018 | Colombia/Spain |